(Q42725041)

5 November 2017

Implication of cell kinetic changes during the progression of human prostatic cancer (English)

1 reference

5 November 2017

R R Berges

1

1 reference

5 November 2017

J Vukanovic

2

1 reference

5 November 2017

J I Epstein

3

1 reference

5 November 2017

M CarMichel

4

1 reference

5 November 2017

L Cisek

5

1 reference

5 November 2017

D E Johnson

6

1 reference

5 November 2017

R W Veltri

7

1 reference

5 November 2017

P C Walsh

8

1 reference

5 November 2017

J T Isaacs

9

1 reference

5 November 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

5 November 2017

Clinical Cancer Research

1 reference

5 November 2017

1

1 reference

5 November 2017

5

1 reference

5 November 2017

473-480

1 reference

Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation

5 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Prostatic intraepithelial neoplasia and invasive carcinoma in total prostatectomy specimens: distribution, volumes and DNA ploidy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Prostate tumor biology and cell kinetics--theory

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Proliferative Activity of Benign Human Prostate, Prostatic Adenocarcinoma and Seminal Vesicle Evaluated by Thymidine Labeling

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Experimental and theoretical basis for hormonal treatment of prostatic cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Non-hormone chemotherapy for prostate cancer: principles of treatment and application to the testing of new drugs.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation-associated antibody Ki-67 and propidium iodide: analysis by flow cytometry

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Programmed death of nonproliferating androgen-independent prostatic cancer cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Pathological and clinical associations of Ki-67 defined growth fractions in human prostatic carcinoma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Androgen regulation of programmed death of normal and malignant prostatic cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Prostatic intraepithelial neoplasia (PIN): Current concepts

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Immunohistochemical determination of age related proliferation rates in normal and benign hyperplastic human prostates.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086477

Activation of a Ca2+-Mg2+-dependent endonuclease as an early event in castration-induced prostatic cell death

16 August 2018

1 reference

12 December 2020

Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67

1 reference

12 December 2020

The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin

1 reference

12 December 2020

Evaluation of average life span of epithelial and stromal cells of human prostate by superoxide dismutase activity

1 reference

12 December 2020

Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation

1 reference

12 December 2020

Hormonally responsive versus unresponsive progression of prostatic cancer to antiandrogen therapy as studied with the Dunning R-3327-AT and -G rat adenocarcinomas

1 reference

12 December 2020

Evaluation of Ki-67 monoclonal antibody as prognostic indicator for prostatic carcinoma

1 reference

12 December 2020

Determination of growth fraction in advanced prostate cancer by Ki-67 immunostaining and its relationship to the time to tumor progression after hormonal therapy

1 reference

12 December 2020

S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling

1 reference

12 December 2020

Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease

1 reference

12 December 2020

Activation of programmed cell death in the rat ventral prostate after castration

1 reference

12 December 2020

Identifiers

1 reference

5 November 2017

PubMed publication ID

9816006

1 reference